Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 40,000 shares of Avidity Biosciences stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $35.07, for a total transaction of $1,402,800.00. Following the completion of the transaction, the director now directly owns […]
Royal Bank of Canada lifted its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 14.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,831,624 shares of the medical research company’s stock after acquiring an additional 751,947 shares during the period. […]
RadNet, Inc. (NASDAQ:RDNT – Get Free Report) COO Norman R. Hames sold 15,000 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $61.15, for a total value of $917,250.00. Following the sale, the chief operating officer now directly owns 280,919 shares in the company, […]
RadNet, Inc. (NASDAQ:RDNT – Get Free Report) Director Christine Nayoma Gordon sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $61.03, for a total transaction of $91,545.00. Following the sale, the director now owns 10,879 shares in the company, […]
Point72 Asset Management L.P. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,666,883 shares of the company’s stock, valued at approximately $112,356,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Headlands Technologies LLC acquired […]